SCHEMBL16665367

SCHEMBL16665367

C=CC(=O)Nc1ccccc1Nc1cc(Oc2ccc3c(c2)cc(C)n3C)ccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 8/20 0.49
FGFR1 P11362 5/20 0.45
FGFR2 P21802 2/20 0.42
FGFR3 P22607 1/20 0.42
MAPK3 P27361 2/20 0.42
MAPK1 P28482 1/20 0.42
MAP2K1 Q02750 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
BRAF P15056 4/20 0.42
RAF1 P04049 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SRC P12931 2/20 0.41
MAP3K7 O43318 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
PDGFRB P09619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16665341 0.86 BRAF (0.45) HTR2CHTR2BBRAFRAF1KDM4E
SCHEMBL16665300 0.85 FGFR4 (0.46) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665246 0.81 FGFR4 (0.56) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665334 0.81 GCK (0.54) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665247 0.80 FGFR4 (0.48) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665335 0.80 FGFR4 (0.59) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665339 0.79 FGFR4 (0.44) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665336 0.79 FGFR4 (0.55) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665295 0.77 FGFR4 (0.50) FGFR4FGFR1FGFR2FGFR3MAPK3
SCHEMBL16665302 0.77 MAPK3 (0.50) FGFR4FGFR1FGFR2FGFR3MAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015057963-A1 FGFR4 INHIBITORS EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-04-23 WO disclosed